The global pharmaceutical market is a rapidly growing sector. In 2018, it was valued at over $1.1 trillion and is projected to reach $1.5 trillion by 2023. With such a substantial market size, many investors are looking for opportunities to invest in the pharmaceutical industry.
Why invest in pharmaceutical brands?
One of the biggest advantages of investing in pharmaceutical companies is that they are recession-proof. Regardless of the state of the economy, people still need medication and healthcare. Additionally, pharmaceutical companies have a large barrier to entry, as developing new drugs and getting them approved by regulatory agencies can take years and require significant investment.
The appeal of Johnson & Johnson and Pfizer
Two of the biggest names in the pharmaceutical industry are Johnson & Johnson and Pfizer. These companies have a long-standing reputation for producing high-quality drugs and investing in research and development.Johnson & Johnson is a diversified healthcare company that operates in three main segments: medical devices, pharmaceuticals, and consumer health. The company’s pharmaceutical division has a portfolio of drugs in a variety of therapeutic areas, including oncology, immunology, and infectious diseases. With over 130 years of experience, Johnson & Johnson is a reliable and stable investment option.Pfizer is another well-known pharmaceutical brand with a long history of success. The company’s portfolio includes drugs to treat cardiovascular disease, cancer, inflammation, and more. In recent years, Pfizer has expanded its focus to include biosimilars and innovative new drugs, setting the company up for continued growth.
Investing in the pharmaceutical sector can be a wise choice for those seeking stable, long-term growth opportunities. Renowned brands such as Johnson & Johnson and Pfizer offer investors a chance to be part of a successful and profitable industry.